result
toxicolog
pharmacolog
studi
iron
ii
coordin
complex
immunoact
dipeptid
isoleucyltryptophan
timof
present
establish
timof
practic
nontox
exhibit
high
immunostimulatori
activ
combin
viral
bacteri
vaccin
sever
studi
demonstr
metalion
fe
zn
ag
coordin
complex
lowmolecularmass
tryptophancontain
peptid
possess
immunoact
pharmacolog
properti
previous
synthesi
dosag
form
prepar
iron
ii
complex
isoleucyltryptophan
dipeptid
timof
report
present
work
report
toxic
data
immunomodulatori
activ
timof
toxicolog
properti
timof
studi
accord
current
rule
preclin
trial
acut
toxic
toler
timof
studi
mice
dog
timof
inject
im
white
laboratori
mice
sex
g
total
volum
ml
maximum
volum
anim
speci
test
determin
acut
toxic
inject
dose
mgkg
test
anim
control
experi
receiv
im
normal
salin
nacl
toler
timof
assess
experi
four
mongrel
dog
sex
kg
drug
inject
im
ml
allow
anim
speci
inject
dose
instanc
mgkg
greater
time
therapeut
dose
human
consid
interspeci
dose
toler
anim
observ
two
week
start
experi
effect
timof
biochem
blood
paramet
studi
im
inject
rat
sex
dose
mgkg
studi
embryotox
white
laboratori
rat
estim
preand
postimplant
embryon
death
morpholog
anatom
develop
abnorm
overal
delay
embryo
develop
inject
timof
dose
mgkg
equival
therapeut
time
therapeut
dose
human
consid
interspeci
dose
toler
cyclophosphamid
possess
embryotox
activ
serv
refer
drug
inject
th
day
pregnanc
dose
mgkg
posit
control
specif
pharmacolog
activ
timof
dose
mgml
per
kg
live
mass
studi
combin
associ
vaccin
enter
rotaand
coronavirus
calf
colibacteriosi
experi
use
calv
divid
two
group
test
calv
control
calv
associ
formol
vaccin
enter
rotaand
coronavirus
calf
colibacteriosi
prepar
ya
r
kovalenko
allrussian
research
institut
experiment
veterinari
medicin
inject
im
twice
interv
dose
ml
complet
studi
show
mice
unaffect
timof
inject
dose
sign
intox
observ
inject
timof
whole
rang
studi
dose
death
test
anim
note
dynam
observ
bodymass
dynam
demand
food
water
test
anim
differ
significantli
control
mice
patholog
chang
compar
control
found
dissect
macroand
microscop
inspect
intern
organ
surviv
test
anim
receiv
test
drug
dog
receiv
timof
normal
demand
food
water
bodymass
chang
lethal
outcom
occur
patholog
chang
found
dissect
macroand
microscop
inspect
intern
organ
test
anim
chronic
toxic
timof
studi
dose
studi
determin
initi
instanc
previous
develop
timogen
zao
medicobiolog
scientificproduct
complex
cytom
st
petersburg
trade
name
timogen
select
closest
pharmacolog
chemicaltechn
analog
onetim
therapeut
dose
previous
studi
timogen
human
mg
dipeptid
ml
administr
per
day
therefor
base
therapeut
dose
timof
also
mg
ml
per
day
drug
inject
im
laboratori
white
rat
dose
mgkg
equival
therapeut
time
therapeut
dose
human
consid
interspeci
dose
toler
paramet
rat
peripher
blood
hemoglobin
erythrocyt
leukocyt
color
paramet
platelet
test
anim
differ
statist
significantli
control
timof
inject
dose
test
show
timof
affect
gener
condit
rat
chang
biochem
blood
paramet
test
anim
tabl
rabbit
experi
confirm
rat
data
singl
im
inject
per
day
timof
dose
mgkg
equival
therapeut
time
therapeut
dose
human
consid
interspeci
dose
toler
chang
gener
condit
anim
toxic
effect
timof
dose
caus
deviat
biochem
blood
paramet
patholog
chang
observ
accord
dissect
macroand
microscop
inspect
intern
organ
test
anim
receiv
test
drug
embryotox
studi
show
cyclophosphamid
dose
mgkg
timof
dose
mgkg
affect
number
corpu
lutea
ovari
rat
becam
pregnant
compound
administ
inject
cyclophosphamid
caus
resorpt
fetus
practic
femal
wherea
timof
affect
process
timof
lethal
embryo
wherea
cyclophosphamid
increas
significantli
time
postimplant
death
compound
caus
preimplant
death
embryo
intrauterin
death
fetus
due
cyclophosphamid
relat
increas
lethal
earli
late
term
embryogenesi
consist
signific
increas
earli
late
resorpt
site
cyclophosphamid
reduc
significantli
time
mass
length
embryo
timof
chang
paramet
contrast
cyclophosphamid
embryotox
activ
timof
dose
mgkg
demonstr
fertil
rat
test
control
group
differ
significantli
averag
number
fetus
per
femal
control
group
group
receiv
timof
dose
mgkg
respect
number
pup
differ
control
group
rat
receiv
timof
dose
wherea
cyclophosphamid
decreas
number
time
pup
born
test
femal
differ
control
morpholog
studi
show
anomal
develop
intern
organ
skeleton
fetus
born
test
rat
cyclophosphamid
produc
specif
embryon
develop
anomali
craniolysi
edema
polyand
oligodactyli
anophthalmia
speech
loss
micrognathia
variou
anomali
brain
palat
appendag
kidney
bladder
note
studi
intern
organ
skeleton
rat
fetus
receiv
cyclophosphamid
develop
anomali
note
fetus
rat
receiv
timof
studi
ossif
variou
skelet
section
rat
embryo
show
cyclophosphamid
pronounc
advers
effect
manifest
signific
decreas
length
number
calcif
point
larg
bone
timof
dose
effect
process
condit
offspr
rat
receiv
timof
dose
whole
pregnanc
observ
one
month
bodi
mass
physic
endur
pubesc
time
eye
open
peel
ear
record
result
show
timof
studi
dose
teratogen
effect
anomali
deform
observ
mass
rat
physic
endur
estim
hang
time
horizont
rod
differ
one
month
birth
control
thu
timof
therapeut
time
therapeut
dose
advers
effect
pregnanc
develop
rat
offspr
vaccin
studi
specif
pharmacolog
activ
timof
combin
associ
vaccin
enter
rotaand
coronavirus
calf
colibacteriosi
select
includ
viral
bacteri
antigen
bovin
blood
serum
immun
contain
antibodi
rotaviru
eia
titer
log
coronaviru
haia
log
escherichia
coli
antibodi
titer
rotaviru
eia
immun
first
second
anim
group
reach
log
respect
coronaviru
haia
log
e
coli
ra
lysozym
bactericid
activ
blood
serum
anim
administ
prepar
respect
antibodi
titer
greater
anim
receiv
timof
togeth
vaccin
receiv
vaccin
ie
rotaviru
time
coronaviru
time
e
coli
twice
lysozym
activ
increas
time
bactericid
time
therefor
timof
increas
level
humor
immun
respons
nonspecif
infect
resist
factor
exhibit
high
immunomodulatori
properti
thu
research
show
timof
nontox
drug
exhibit
immunomodulatori
properti
promis
pharmaceut
industri
